Indaptus Therapeutics, Inc. — Form D
Indaptus Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-20. The offering totals $5.0M, of which $2.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-06-20
- Form: D
- Accession: 0001641172-25-015841
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $5.0M
- Amount sold: $2.3M
- Remaining: $2.7M
- Investors: 20
- Date of first sale: 2025-06-12
- Revenue range: Decline to Disclose
- SEC file number: 021-549477
Issuer
- Name: Indaptus Therapeutics, Inc.
- CIK: 0001857044
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 3 COLUMBUS CIRCLE, NEW YORK, NY, 10019
- Phone: (646) 427-2727
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| William B Hayes | Director | New York, NY |
| Hila J Karah | Director | New York, NY |
| Anthony J Maddaluna | Director | New York, NY |
| Robert E Martell | Director | New York, NY |
| JEFFREY A MECKLER | Director | TUCKER, GA |
| Michael J Newman | Director | New York, NY |
| Roger J Pomerantz | Director | New York, NY |
| JEFFREY A MECKLER | Executive Officer | TUCKER, GA |
| Michael J Newman | Executive Officer | New York, NY |
| Nir J Sassi | Executive Officer | New York, NY |
| Roger J Waltzman | Executive Officer | New York, NY |
| MARK J GILBERT | Director | NEW YORK, NY |
| NIR A SASSI | Executive Officer | NEW YORK, NY |
| WALT A LINSCOTT | Executive Officer | NEW YORK, NY |
| HOONMO A LEE | Director | NEW YORK, NY |
| MICHAEL A NEWMAN | Director | NEW YORK, NY |
| MICHAEL A NEWMAN | Executive Officer | NEW YORK, NY |
| HILA W KARAH | Director | NEW YORK, NY |
| BRIAN J O'CALLAGHAN | Director | NEW YORK, NY |
Other filings by this issuer (5)
More